BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25442380)

  • 41. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
    Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
    Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
    Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.
    Aguilar CA; Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Ussetti P; Chin-Hong PV; Sole A; Holmes-Liew C; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Singer LG; Husain S
    J Heart Lung Transplant; 2018 Oct; 37(10):1226-1234. PubMed ID: 30139546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acute invasive pulmonary aspergillosis in chronic lung disease--a review].
    Ader F; Nseir S; Guery B; Tillie-Leblond I
    Rev Mal Respir; 2006 Jun; 23(3 Suppl):6S11-6S20. PubMed ID: 16820744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Spectrum and risk factors of invasive fungal infection].
    Osorio JJ; Román AR; Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 2007; 25(7):467-76. PubMed ID: 17692214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasive fungal infections in liver transplantation.
    Liu X; Ling Z; Li L; Ruan B
    Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fungal infections in transplantation patients].
    Colomba C; Antinori S
    Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
    Sav H; Atalay MA; Unal E; Koç N
    Mikrobiyol Bul; 2012 Oct; 46(4):695-701. PubMed ID: 23188584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Procalcitonin serum concentration in lung transplant recipients during mold colonization or infection.
    Zegleń S; Sioła M; Woźniak-Grygiel E; Łaszewska A; Sindera P; Wojarski J; Ochman M; Kucewicz E; Karolak W; Szewczyk M; Zembala M
    Transplant Proc; 2011 Oct; 43(8):3089-91. PubMed ID: 21996233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
    Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
    Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of anidulafungin in solid organ transplant recipients.
    Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
    Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis.
    Egli A; Fuller J; Humar A; Lien D; Weinkauf J; Nador R; Kapasi A; Kumar D
    Transplantation; 2012 Aug; 94(4):403-10. PubMed ID: 22805441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
    De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
    Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy Strategy.
    Herrera S; Davoudi S; Farooq A; Tikkanen J; Foroutan F; Kumar D; Humar A; Rotstein C; Singer LG; Keshavjee S; Husain S
    Transplantation; 2020 Dec; 104(12):2575-2581. PubMed ID: 32080158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
    Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
    Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Aspergillus tracheobronchitis in a lung transplant recipient].
    García-Gallo CL; García-Fadul C; Laporta-Hernández R; Ussetti-Gil P
    Rev Iberoam Micol; 2011; 28(3):129-33. PubMed ID: 21700233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preemptive treatment with voriconazole in lung transplant recipients.
    Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey CO; Slavin MA; Stewart K; Kong DC
    Transpl Infect Dis; 2013 Aug; 15(4):344-53. PubMed ID: 23527908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
    Pinney MF; Rosenberg AF; Hampp C; Schain D; Akindipe O; Baz M
    Pharmacotherapy; 2011 Jun; 31(6):537-45. PubMed ID: 21923437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.
    Luong ML; Clancy CJ; Vadnerkar A; Kwak EJ; Silveira FP; Wissel MC; Grantham KJ; Shields RK; Crespo M; Pilewski J; Toyoda Y; Kleiboeker SB; Pakstis D; Reddy SK; Walsh TJ; Nguyen MH
    Clin Infect Dis; 2011 May; 52(10):1218-26. PubMed ID: 21507918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.